Sanj Patel, center, President and CEO of Synageva BioPharma Corp., attends the opening bell ceremony at Nasdaq with colleagues and guests, Thursday, Nov. 3, 2011 in New York. Synageva, based in ... more 
Sanj Patel, center, President and CEO of Synageva BioPharma Corp., attends the opening bell ceremony at Nasdaq with colleagues and guests, Thursday, Nov. 3, 2011 in New York. Synageva, based in Lexington, Mass., develops drugs for patients with life-threatening rare diseases. (AP Photo/Mark Lennihan) less 
1 / 1
Associated Press | Photo By Mark Lennihan
Thu, Nov 3, 2011 10:54 AM EDT